TFPI and neoplasm: Proposed chemotherapeutic mechanisms include interference with cellular proliferation, release of tissue factor pathway inhibitor (TFPI) from vascular endothelium, anti-inflammatory properties, and inhibition of heparanase activity resulting in decreased tumor invasion and metastasis [48,49].